Product Information
PREGABALIN 75 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.0528 per EA under NDC 62135044590. Its NADAC has been published 169 times since Jul 12, 2023.
FDA first approved this application on Mar 20, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Chartwell RX LLCNDC
62135044590
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA212865FDA Approved
3/20/2020
TE Code
AB
On Market Since
3/31/2020
Price Statistics
The NADAC for PREGABALIN 75 MG CAPSULE has been published 169 times since Jul 12, 2023, and over the history we have for it it has declined 29.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0528 per EA |
|---|---|
| All-time high | $0.0751 (Jul 12, 2023) |
| All-time low | $0.0433 (Nov 20, 2024) |
| 52-week high | $0.0628 |
| 52-week low | $0.0494 |
| Median price | $0.0597 |
| Average price | $0.0580 |
| Largest weekly change | +39.8% (Aug 21, 2024) |
| Weeks tracked | 169 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pregabalin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREGABALIN 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 75 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.0528 per EA (NDC 62135044590), effective Sep 30, 2026.
How has the price of PREGABALIN 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 75 MG CAPSULE has declined 29.7%. It has been tracked across 169 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for PREGABALIN 75 MG CAPSULE?
Since Jul 12, 2023, the NADAC for PREGABALIN 75 MG CAPSULE has ranged from a low of $0.0433 (Nov 20, 2024) to a high of $0.0751 (Jul 12, 2023), with a median of $0.0597 per EA.
Are there cheaper alternatives to PREGABALIN 75 MG CAPSULE?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 75 MG CAPSULE, is $0.0513 per EA — about 3% below PREGABALIN 75 MG CAPSULE.
Who manufactures PREGABALIN 75 MG CAPSULE?
PREGABALIN 75 MG CAPSULE (NDC 62135044590) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.